NEVVI Medicare utilization intelligence
or

← back

Provider profile

LANGERAK, ALAN MD

Hematology-Oncology · NPI 1902853294 · PRESCOTT, AZ

2
Groups
57
Codes · 2024
126,969
Disclosed services

LANGERAK, ALAN is a Hematology-Oncology in PRESCOTT, AZ, a member of 2 medical groups, who billed 57 distinct codes to Medicare Part B in 2024.

Groups: ARIZONA ONCOLOGY ASSOCIATES PC (TUCSON, AZ) · CITY OF HOPE MEDICAL GROUP OF ARIZONA LLC (GOODYEAR, AZ) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

LANGERAK, ALAN billed 158,157 disclosed services in CY2023 and 126,969 in CY2024.

This provider's disclosed Medicare payments across all codes were $ in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0897 Injection, denosumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
J9395 Injection, fulvestrant, 25 mg
J3489 Injection, zoledronic acid, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96523 Irrigation of implanted venous access drug delivery device
96372 Injection of drug or substance under skin or into muscle
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3475 Injection, magnesium sulfate, per 500 mg
J3480 Injection, potassium chloride, per 2 meq
J9190 Injection, fluorouracil, 500 mg
J9045 Injection, carboplatin, 50 mg
J7030 Infusion, normal saline solution , 1000 cc
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96361 Infusion into a vein for hydration, each additional hour
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96360 Infusion into a vein for hydration, 31-60 minutes
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
99195 Drawing of blood for a medical problem
71260 Ct scan of chest with contrast
J3490 Unclassified drugs
74177 Ct scan of abdomen and pelvis with contrast
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
78816 Nuclear medicine study whole body with ct scan
71250 Ct scan of chest without contrast
36415 Insertion of needle into vein for collection of blood sample

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.